Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Martine van Bilzen"'
Autor:
René Post, Menno R Germans, Maud A Tjerkstra, Mervyn D I Vergouwen, Korné Jellema, Radboud W Koot, Nyika D Kruyt, Peter W A Willems, Jasper F C Wolfs, Frits C de Beer, Hans Kieft, Dharmin Nanda, Bram van der Pol, Gerwin Roks, Frank de Beer, Patricia H A Halkes, Loes J A Reichman, Paul J A M Brouwers, Renske M van den Berg-Vos, Vincent I H Kwa, Taco C van der Ree, Irene Bronner, Janneke van de Vlekkert, Henri P Bienfait, Hieronymus D Boogaarts, Catharina J M Klijn, René van den Berg, Bert A Coert, Janneke Horn, Charles B L M Majoie, Gabriël J E Rinkel, Yvo B W E M Roos, W Peter Vandertop, Dagmar Verbaan, Menno R. Germans, Maud A. Tjerkstra, Mervyn D.I. Vergouwen, Radboud W. Koot, Nyika D. Kruyt, Peter W.A. Willems, Jasper F.C. Wolfs, Frits C. de Beer, Patricia H.A. Halkes, Loes J.A. Reichman, Paul J.A.M. Brouwers, Renske M. van den Berg-Vos, Vincent I.H. Kwa, Taco C. van der Ree, Henri P. Bienfait, Hieronymus D. Boogaarts, Catharina J.M. Klijn, Martine van Bilzen, H.J.G. Dieks, Koen de Gans, J.B.M. ten Holter, Jelle R. de Kruijk, Charlie T.J.M. Leijzer, Delmar Molenaar, Robbert J. van Oostenbrugge, Jeske van Pamelen, Fianne H.M. Spaander, Sarah E. Vermeer, J. Manuela Voorend, Bert A. Coert, Charles B.L.M. Majoie, Gabriël J.E. Rinkel, Yvo B.W.E.M. Roos, W. Peter Vandertop
Publikováno v:
Lancet, 397(10269), 112-118. Elsevier Limited
The Lancet (London), 397, 10269, pp. 112-118
ULTRA Investigators 2021, ' Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA) : a randomised controlled trial ', Lancet, vol. 397, no. 10269, pp. 112-118 . https://doi.org/10.1016/S0140-6736(20)32518-6
The Lancet (London), 397, 112-118
The Lancet, 397(10269), 112-118. ELSEVIER SCIENCE INC
The Lancet (London), 397, 10269, pp. 112-118
ULTRA Investigators 2021, ' Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA) : a randomised controlled trial ', Lancet, vol. 397, no. 10269, pp. 112-118 . https://doi.org/10.1016/S0140-6736(20)32518-6
The Lancet (London), 397, 112-118
The Lancet, 397(10269), 112-118. ELSEVIER SCIENCE INC
BACKGROUND: In patients with aneurysmal subarachnoid haemorrhage, short-term antifibrinolytic therapy with tranexamic acid has been shown to reduce the risk of rebleeding. However, whether this treatment improves clinical outcome is unclear. We inves